The groundbreaking approach of the medication represents a major development in the care of diabetes mellitus type 2. Unlike existing drugs, tirzepatide impacts multiple pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide410831.bcbloggers.com/40820602/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment